Old tuberculosis vaccine tested against HIV's secret stash
NCT ID NCT05004038
First seen May 08, 2026 · Last updated May 10, 2026 · Updated 1 time
Summary
This study tested whether the BCG vaccine, normally used for tuberculosis, could reduce the amount of hidden HIV in the body. 60 people with HIV on stable antiretroviral therapy received either the BCG vaccine or a placebo. The main goal was to measure changes in the HIV reservoir after 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Zurich
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.